Incorporated in 2015, Co. is in the business of manufacturing pharmaceutical products for different marketers on a loan license or contract manufacturing basis
Sotac Pharma secured a Rs. 0.98 Cr purchase order from Intas Pharmaceuticals for finished pharmaceutical formulations. Supplies are scheduled between September and November 2026, bolstering the company's existing order book.
Submission of Structural Digital Database Compliance Certificate under SEBI (Prohibition of Insider Trading) Regulations, 2015, for the year ended 31st March, 2026.
Sharadkumar Dashrathbhai Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Sotac Pharmaceuticals Limited has informed regarding Submission of Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended on March 31, 2026.